These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3490938)

  • 21. The host response in graft versus host disease. I. Radiosensitive T cells of host origin inhibit parental anti-F1 cytotoxicity in murine chronic graft versus host disease.
    Singh AB; Hiehle K; Singh M; Jetzt AE; O'Connell SM; Mann RA
    Cell Immunol; 1993 Oct; 151(1):24-38. PubMed ID: 8402929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of H-2 mutations in mice. VII. The defectiveness of the H-2ba mutant in the hemagglutination and graft vs host reactions].
    Mnatsakanian IuA; Pospelov LE; Egorov IK
    Genetika; 1977; 13(1):64-9. PubMed ID: 25825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the specificity of autoantibodies produced in systemic graft-vs-host disease.
    Streilein JW; Stone MJ; Duncan WR
    J Immunol; 1975 Jan; 114(1 Pt 2):255-60. PubMed ID: 234989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H-2 I region restriction phenomenon in T cell-dependent granuloma formation to Mycobacterium bovis BCG.
    Ueda K; Yamazaki S; Yamamoto S
    J Reticuloendothel Soc; 1983 Dec; 34(6):475-84. PubMed ID: 6418887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
    Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
    J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice.
    Cawley D; Chiang BL; Naiki M; Ansari AA; Gershwin ME
    J Immunol; 1993 Mar; 150(6):2467-77. PubMed ID: 8450223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conventional B cells, not B1 cells, are the source of autoantibodies in chronic graft-versus-host disease.
    Reap EA; Sobel ES; Jennette JC; Cohen PL; Eisenberg RA
    J Immunol; 1993 Dec; 151(12):7316-23. PubMed ID: 7505027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of autoreactive T-cell clones from NZB.H-2bm12 mice.
    Naiki M; Yoshida SH; Ansari AA; Bill J; Gershwin ME
    J Autoimmun; 1994 Jun; 7(3):275-90. PubMed ID: 7916904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
    Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
    J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. Identification of a CD44hi population that binds specifically to hyaluronate.
    Murakami S; Miyake K; Abe R; Kincade PW; Hodes RJ
    J Immunol; 1991 Mar; 146(5):1422-7. PubMed ID: 1993837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the treatment of parental cells in vitro with anti-T antibody on bone marrow transplantation in F1 hybrid mice.
    Hrubá A; Paluska E; Fricová V; Fiala J
    Folia Biol (Praha); 1980; 26(5):338-50. PubMed ID: 7002637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutual recognition of parental and F1 lymphocytes. II. Analysis of graft-vs-host-induced suppressor cell activity for T cell-mediated lympholysis to trinitrophenyl self and alloantigens.
    Polisson RP; Shearer GM
    J Immunol; 1980 Oct; 125(4):1865-61. PubMed ID: 6967920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.
    Ikarashi Y; Kawai K; Watanabe H; Matsumoto Y; Omata S; Fujiwara M
    Immunology; 1993 May; 79(1):95-102. PubMed ID: 8099568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
    Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH
    J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific depletion of graft-versus-host activity of normal or allosensitized parental spleen cells.
    Rózalska B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):417-21. PubMed ID: 6200087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic graft versus host disease-associated autoimmune manifestations are independently regulated by different MHC class II loci.
    Bradley DS; Jennette JC; Cohen PL; Eisenberg RA
    J Immunol; 1994 Feb; 152(4):1960-9. PubMed ID: 8120400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.